AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its Effects by Transcriptional Inhibition in Leukemia Cell Lines and Patient Samples
Year: 2010
Type: article
Source: Molecular Cancer Therapeutics
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Astex Pharmaceuticals
OpenAlex ID: W2160656155
